168 related articles for article (PubMed ID: 32440897)
1. Adamantinomatous craniopharyngioma in the molecular age and the potential of targeted therapies: a review.
Whelan R; Hengartner A; Folzenlogen Z; Prince E; Hankinson TC
Childs Nerv Syst; 2020 Aug; 36(8):1635-1642. PubMed ID: 32440897
[TBL] [Abstract][Full Text] [Related]
2. The Inflammatory Milieu of Adamantinomatous Craniopharyngioma and Its Implications for Treatment.
Whelan R; Prince E; Gilani A; Hankinson T
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32075140
[TBL] [Abstract][Full Text] [Related]
3. Adamantinomatous craniopharyngioma: moving toward targeted therapies.
Hengartner AC; Prince E; Vijmasi T; Hankinson TC
Neurosurg Focus; 2020 Jan; 48(1):E7. PubMed ID: 31896087
[TBL] [Abstract][Full Text] [Related]
4. Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma.
Coy S; Rashid R; Lin JR; Du Z; Donson AM; Hankinson TC; Foreman NK; Manley PE; Kieran MW; Reardon DA; Sorger PK; Santagata S
Neuro Oncol; 2018 Jul; 20(8):1101-1112. PubMed ID: 29509940
[TBL] [Abstract][Full Text] [Related]
5. Advancing Craniopharyngioma Management: A Systematic Review of Current Targeted Therapies and Future Perspectives.
Agosti E; Zeppieri M; Antonietti S; Piazza A; Ius T; Fontanella MM; Fiorindi A; Panciani PP
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255797
[TBL] [Abstract][Full Text] [Related]
6. Identification of targets for rational pharmacological therapy in childhood craniopharyngioma.
Gump JM; Donson AM; Birks DK; Amani VM; Rao KK; Griesinger AM; Kleinschmidt-DeMasters BK; Johnston JM; Anderson RC; Rosenfeld A; Handler M; Gore L; Foreman N; Hankinson TC
Acta Neuropathol Commun; 2015 May; 3():30. PubMed ID: 25990246
[TBL] [Abstract][Full Text] [Related]
7. First evidence of anti-VEGF efficacy in an adult case of adamantinomatous craniopharyngioma: Case report and illustrative review.
De Rosa A; Calvanese F; Ducray F; Vasiljevic A; Manet R; Raverot G; Jouanneau E
Ann Endocrinol (Paris); 2023 Dec; 84(6):727-733. PubMed ID: 37865272
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional analyses of adult and pediatric adamantinomatous craniopharyngioma reveals similar expression signatures regarding potential therapeutic targets.
Prince E; Whelan R; Donson A; Staulcup S; Hengartner A; Vijmasi T; Agwu C; Lillehei KO; Foreman NK; Johnston JM; Massimi L; Anderson RCE; Souweidane MM; Naftel RP; Limbrick DD; Grant G; Niazi TN; Dudley R; Kilburn L; Jackson EM; Jallo GI; Ginn K; Smith A; Chern JJ; Lee A; Drapeau A; Krieger MD; Handler MH; Hankinson TC;
Acta Neuropathol Commun; 2020 May; 8(1):68. PubMed ID: 32404202
[TBL] [Abstract][Full Text] [Related]
9. Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma.
Donson AM; Apps J; Griesinger AM; Amani V; Witt DA; Anderson RCE; Niazi TN; Grant G; Souweidane M; Johnston JM; Jackson EM; Kleinschmidt-DeMasters BK; Handler MH; Tan AC; Gore L; Virasami A; Gonzalez-Meljem JM; Jacques TS; Martinez-Barbera JP; Foreman NK; Hankinson TC;
J Neuropathol Exp Neurol; 2017 Sep; 76(9):779-788. PubMed ID: 28859336
[TBL] [Abstract][Full Text] [Related]
10. Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma.
Martinez-Barbera JP
Neuropathol Appl Neurobiol; 2015 Oct; 41(6):721-32. PubMed ID: 25611703
[TBL] [Abstract][Full Text] [Related]
11. Successful Use of BRAF/MEK Inhibitors as a Neoadjuvant Approach in the Definitive Treatment of Papillary Craniopharyngioma.
Khaddour K; Chicoine MR; Huang J; Dahiya S; Ansstas G
J Natl Compr Canc Netw; 2020 Dec; 18(12):1590-1595. PubMed ID: 33285519
[TBL] [Abstract][Full Text] [Related]
12. Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin.
Stache C; Bils C; Fahlbusch R; Flitsch J; Buchfelder M; Stefanits H; Czech T; Gaipl U; Frey B; Buslei R; Hölsken A
Neurosurg Focus; 2016 Dec; 41(6):E14. PubMed ID: 27903123
[TBL] [Abstract][Full Text] [Related]
13. Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy.
Rostami E; Witt Nyström P; Libard S; Wikström J; Casar-Borota O; Gudjonsson O
Acta Neurochir (Wien); 2017 Nov; 159(11):2217-2221. PubMed ID: 28918496
[TBL] [Abstract][Full Text] [Related]
14. The Medical Therapy of Craniopharyngiomas: The Way Ahead.
Alexandraki KI; Kaltsas GA; Karavitaki N; Grossman AB
J Clin Endocrinol Metab; 2019 Dec; 104(12):5751-5764. PubMed ID: 31369091
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy.
Martinez-Gutierrez JC; D'Andrea MR; Cahill DP; Santagata S; Barker FG; Brastianos PK
Neurosurg Focus; 2016 Dec; 41(6):E2. PubMed ID: 27903124
[TBL] [Abstract][Full Text] [Related]
16. Identification and Functional Enrichment Analysis of Potential Diagnostic and Therapeutic Targets in Adamantinomatous Craniopharyngioma.
Zou YF; Meng LB; Wang QQ; He ZK; Hu CH; Shan MJ; Wang DY; Yu X
J Comput Biol; 2020 Jan; 27(1):55-68. PubMed ID: 31424286
[TBL] [Abstract][Full Text] [Related]
17. Intracystic bleomycin for cystic craniopharyngiomas in children.
Zhang S; Fang Y; Cai BW; Xu JG; You C
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008890. PubMed ID: 27416004
[TBL] [Abstract][Full Text] [Related]
18. Histopathology and molecular characterisation of intrauterine-diagnosed congenital craniopharyngioma.
Scagliotti V; Avagliano L; Gualtieri A; Graziola F; Doi P; Chalker J; Righini A; Korbonits M; Bulfamante G; Jacques TS; Massa V; Gaston-Massuet C
Pituitary; 2016 Feb; 19(1):50-6. PubMed ID: 26350256
[TBL] [Abstract][Full Text] [Related]
19. Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis.
Prince EW; Apps JR; Jeang J; Chee K; Medlin S; Jackson EM; Dudley R; Limbrick D; Naftel R; Johnston J; Feldstein N; Prolo LM; Ginn K; Niazi T; Smith A; Kilburn L; Chern J; Leonard J; Lam S; Hersh DS; Gonzalez-Meljem JM; Amani V; Donson AM; Mitra SS; Bandopadhayay P; Martinez-Barbera JP; Hankinson TC
Neuro Oncol; 2024 Jun; 26(6):1109-1123. PubMed ID: 38334125
[TBL] [Abstract][Full Text] [Related]
20. Treatment strategies for craniopharyngiomas.
Ottenhausen M; Rumalla K; La Corte E; Alalade A; Nair P; Forbes J; Ben Nsir A; Schwartz TH
J Neurosurg Sci; 2019 Feb; 63(1):83-87. PubMed ID: 28869375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
